ESR1 and prostate carcinoma: There are several prognostic factors used to determine the outcomes of breast cancer patients, including lymph node involvement, histological grade, age at diagnosis, estrogen receptor (ER), and progesterone receptor (PR) [3].PSA are highly specific and have been established as significant tumor markers in prostate cancer.